155 related articles for article (PubMed ID: 37967839)
21. Identification of cuproptosis-related genes and immune infiltration in dilated cardiomyopathy.
Lin Y; Chen K; Guo J; Chen P; Qian ZR; Zhang T
Int J Cardiol; 2024 Mar; 399():131702. PubMed ID: 38168558
[TBL] [Abstract][Full Text] [Related]
22. Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy.
Zheng Y; Liu Z; Yang X; Weng S; Xu H; Guo C; Xing Z; Liu L; Wang L; Dang Q; Qiu C
Front Cardiovasc Med; 2022; 9():865096. PubMed ID: 35571180
[TBL] [Abstract][Full Text] [Related]
23. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy.
Chen P; Xie Y; Shen E; Li GG; Yu Y; Zhang CB; Yang Y; Zou Y; Ge J; Chen R; Chen H
Eur J Pharmacol; 2011 May; 658(2-3):168-74. PubMed ID: 21371462
[TBL] [Abstract][Full Text] [Related]
24. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
[TBL] [Abstract][Full Text] [Related]
25. Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines.
Bian R; Wang Y; Li Z; Xu X
Front Mol Biosci; 2023; 10():1154920. PubMed ID: 37168258
[No Abstract] [Full Text] [Related]
26. Development and validation of risk prediction and neural network models for dilated cardiomyopathy based on WGCNA.
Yu W; Li L; Tan X; Liu X; Yin C; Cao J
Front Med (Lausanne); 2023; 10():1239056. PubMed ID: 37869159
[TBL] [Abstract][Full Text] [Related]
27. Expression of cytokine genes and presence of enteroviral genomic RNA in endomyocardial biopsy tissues of myocarditis and dilated cardiomyopathy.
Satoh M; Tamura G; Segawa I; Tashiro A; Hiramori K; Satodate R
Virchows Arch; 1996 Feb; 427(5):503-9. PubMed ID: 8624580
[TBL] [Abstract][Full Text] [Related]
28. Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets.
Yuan Z; Murakoshi N; Xu D; Tajiri K; Okabe Y; Aonuma K; Murakata Y; Li S; Song Z; Shimoda Y; Mori H; Aonuma K; Ieda M
Life Sci; 2022 Oct; 306():120807. PubMed ID: 35841977
[TBL] [Abstract][Full Text] [Related]
29. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.
Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G
Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of AC061961.2, LING01-AS1, and RP11-13E1.5 is associated with dilated cardiomyopathy progression.
Qiu Z; Ye B; Yin L; Chen W; Xu Y; Chen X
J Cell Physiol; 2019 Apr; 234(4):4460-4471. PubMed ID: 30203513
[TBL] [Abstract][Full Text] [Related]
31. Identification of Signature Genes of Dilated Cardiomyopathy Using Integrated Bioinformatics Analysis.
Wu Z; Wang X; Liang H; Liu F; Li Y; Zhang H; Wang C; Wang Q
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108502
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Regulation and Function of
Bajpai AK; Gu Q; Orgil BO; Alberson NR; Towbin JA; Martinez HR; Lu L; Purevjav E
Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254943
[TBL] [Abstract][Full Text] [Related]
34. Construction of Immune-Related ceRNA Network in Dilated Cardiomyopathy: Based on Sex Differences.
Liu C; Liu J; Wu D; Luo S; Li W; Chen L; Liu Z; Yu B
Front Genet; 2022; 13():882324. PubMed ID: 35754849
[No Abstract] [Full Text] [Related]
35. Identification of the distinctive role of DPT in dilated cardiomyopathy: a study based on bulk and single-cell transcriptomic analysis.
Lu Y; Wu Q; Liao J; Zhang S; Lu K; Yang S; Wu Y; Dong Q; Yuan J; Zhao N; Du Y
Ann Transl Med; 2021 Sep; 9(18):1401. PubMed ID: 34733953
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic Variants Associated With Dilated Cardiomyopathy Predict Outcome in Pediatric Myocarditis.
Seidel F; Holtgrewe M; Al-Wakeel-Marquard N; Opgen-Rhein B; Dartsch J; Herbst C; Beule D; Pickardt T; Klingel K; Messroghli D; Berger F; Schubert S; Kühnisch J; Klaassen S
Circ Genom Precis Med; 2021 Aug; 14(4):e003250. PubMed ID: 34213952
[TBL] [Abstract][Full Text] [Related]
37. Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis.
Guo Q; Qu Q; Wang L; Liao S; Zhu X; Du A; Zhu Q; Cheang I; Gao R; Li X
Front Biosci (Landmark Ed); 2022 Aug; 27(8):246. PubMed ID: 36042172
[TBL] [Abstract][Full Text] [Related]
38. Myocardial DNA strand breaks are detected in biopsy tissues from patients with dilated cardiomyopathy.
Seki Y; Kai H; Kai M; Muraishi A; Adachi K; Imaizumi T
Clin Cardiol; 1998 Aug; 21(8):591-6. PubMed ID: 9702387
[TBL] [Abstract][Full Text] [Related]
39. Identification of immune-related key genes in the peripheral blood of ischaemic stroke patients using a weighted gene coexpression network analysis and machine learning.
Zheng PF; Chen LZ; Liu P; Pan HW; Fan WJ; Liu ZY
J Transl Med; 2022 Aug; 20(1):361. PubMed ID: 35962388
[TBL] [Abstract][Full Text] [Related]
40. Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and
Zhou L; Peng F; Li J; Gong H
Exp Ther Med; 2023 Jul; 26(1):325. PubMed ID: 37346398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
